Lumoptik, Inc.
PrivateLast Round
Seed Round
Jan 16, 2026
Total Funding Raised
$1.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lumoptik, Inc. operates in Healthcare & Life Sciences and is based in Spring Grove, Illinois. Its latest recorded funding round was a Corporate Funding round in October 2022.
Lumoptik, Inc. is a medical device company that has developed the BrightPoint needle guidance system to assist physicians with needle placement during epidural and other surgical procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumoptik, Inc. Comparables
Compare Lumoptik, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GuideStar Medical Devices | 85% | |
| Often Medical | 84% | |
| Ethos Medical | 84% |
For institutional investors. Book with your work email.
Lumoptik, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jan 16, 2026 | ||||
| Corporate Funding | Oct 1, 2022 | ||||
| Seed | Mar 1, 2021 | ||||
| Seed | May 21, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lumoptik, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TCA Venture Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 16, 2026
Raised $1.5M in Seed funding.
- Jan 25, 2025
Monthly visitors increased 800% MoM.
For institutional investors. Book with your work email.
Lumoptik, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lumoptik, Inc.'s valuation, stock price, and market status.
Is Lumoptik, Inc. a public or private company?
Lumoptik, Inc. is a private company.
What is the current stock price of Lumoptik, Inc.?
Lumoptik, Inc. is a private company, so its shares have no public market price. Caplight tracks Lumoptik, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lumoptik, Inc. worth (valuation)?
Valuation information for Lumoptik, Inc. is not publicly available.
Can I buy Lumoptik, Inc. stock?
Lumoptik, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lumoptik, Inc.'s last funding round?
Lumoptik, Inc.'s most recent funding round was Seed Round on January 16, 2026.
Who are the main investors in Lumoptik, Inc.?
Key investors in Lumoptik, Inc. include TCA Venture Group.
Will Lumoptik, Inc. IPO soon?
No public IPO plans have been announced for Lumoptik, Inc..
How can I track Lumoptik, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Lumoptik, Inc.'s shares on secondary markets.